Sage Therapeutics, Inc.

Ownership Transactions Reported by 16 Insiders

Symbol
SAGE on Nasdaq
Location
215 First Street, Cambridge, Massachusetts

There are no Buy or Sell transactions made by insiders since 9/12/2023

Sage Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Jeffrey M. Jonas Director $2.47M Jun 10, 2024
Greene Barry E President and CEO, Director $762K Aug 5, 2024
Iguchi Kimi CFO & Treasurer $729K Aug 5, 2024
Stephen Kanes Chief Medical Officer $260K Oct 19, 2021
Cook Anne Marie SVP, GC & Secretary $215K Aug 5, 2024
Christopher Benecchi Chief Business Officer $166K Aug 5, 2024
Laura Gault Chief Medical Officer $96.2K Aug 5, 2024
Elizabeth Barrett Director $57.8K Jun 10, 2024
Michael F. Cola Director Jun 10, 2024
Kevin P. Starr Director Jun 15, 2023
James M. Frates Director Jun 10, 2024
Geno J. Germano Director Jun 10, 2024
George Golumbeski Director Jun 10, 2024
Albert Robichaud Chief Scientific Officer Feb 13, 2023
Jessica Federer Director Jun 10, 2024
Steven M. Paul Director Jan 3, 2024

Recent Insider Transactions by Companies or Individuals for Sage Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.